Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of imatinib mesylate versus nilotinib
2012-000770-36Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of imatinib and nilotinib, sponsored by CHU de Lille. Started Aug 2012; status: completed.
02
Drugs
imatinibnilotinib
Beyond the preview
Go deeper on 2012-000770-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000770-36.